Skip to main content
. Author manuscript; available in PMC: 2022 Oct 11.
Published in final edited form as: Acta Neuropathol. 2022 Jun 13;144(1):27–44. doi: 10.1007/s00401-022-02444-1

Table 5.

Numbers of participants with complete data on LATE-NC stages, Braak NFT stages, and Thal Aβ phases, stratified according to all three pathologic readouts (n = 3803)*

LATE-NC stage 0 Braak NFT stages
Total
0 I II III IV V VI

Thal Aβ phases 0 110 136 176 128 80 4 0 634
1 18 76 119 130 101 7 1 452
2 16 23 72 54 37 5 2 209
3 7 34 62 130 119 55 8 415
4 2 10 15 58 106 115 17 323
5 0 4 10 23 58 138 68 301
2334

LATE-NC stage 1 Braak NFT stages
Total
0 I II III IV V VI

Thal Aβ phases 0 4 9 15 22 10 2 0 62
1 1 8 23 34 31 2 0 99
2 1 2 8 10 7 0 1 29
3 2 7 8 28 40 28 3 116
4 0 1 0 9 48 32 7 97
5 0 0 1 6 19 69 21 116
519

LATE-NC stage 2 Braak NFT stages
Total
0 I II III IV V VI

Thal Aβ phases 0 3 12 9 16 32 3 0 75
1 1 6 21 22 45 7 1 103
2 0 0 5 22 21 3 1 52
3 0 2 11 20 54 40 7 134
4 0 0 2 10 53 112 11 188
5 0 0 1 6 31 131 61 230
782

LATE-NC stage 3 Braak NFT stages
Total
0 I II III IV V VI

Thal Aβ phases 0 2 2 3 4 5 0 0 16
1 2 7 5 5 2 0 0 21
2 0 1 1 2 1 0 0 5
3 0 2 1 6 15 14 1 39
4 0 2 1 2 11 14 3 33
5 0 0 2 2 6 32 12 54
168
*

For the numbers of cases contributory from each cohort, see Supplemental Table 3, online resource